Astria Therapeutics (NASDAQ:ATXS) Trading Down 2.9% on Analyst Downgrade : vimarsana.com

Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report)’s stock price was down 2.9% during mid-day trading on Tuesday after HC Wainwright lowered their price target on the stock from $18.00 to $16.00. HC Wainwright currently has a buy rating on the stock. Astria Therapeutics traded as low as $9.51 and last traded at $9.52. Approximately […]

Related Keywords

United States , Christopher Morabito , Capital Management , Perceptive Advisors Llc , Jump Financial , Armistice Capital , Jefferies Financial Group , Affinity Asset Advisors , Nasdaq , Astria Therapeutics Inc , Perceptive Advisors , Astria Therapeutics , Get Free Report , Financial Group , Director Perceptive Advisors Llc , Asset Advisors , Astria Therapeutics Daily ,